Humacyte (NASDAQ:HUMA) Receives New Coverage from Analysts at HC Wainwright
HC Wainwright assumed coverage on shares of Humacyte (NASDAQ:HUMA – Free Report) in a report issued on Monday morning, MarketBeat reports. The brokerage issued a buy rating and a $6.00 price target on the stock. HC Wainwright also issued estimates for Humacyte’s Q4 2023 earnings at ($0.25) EPS, FY2023 earnings at ($0.94) EPS, FY2024 earnings […]
More Stories
Desjardins Has Positive View of Lundin Gold FY2025 Earnings
Lundin Gold Inc. (TSE:LUG – Free Report) – Desjardins upped their FY2025 earnings estimates for Lundin Gold in a note...
Critical Review: Simon Property Group (NYSE:SPG) vs. Welltower (NYSE:WELL)
Welltower (NYSE:WELL – Get Free Report) and Simon Property Group (NYSE:SPG – Get Free Report) are both large-cap finance companies,...
Scotiabank Has Optimistic Outlook of FSM FY2025 Earnings
Fortuna Silver Mines Inc. (NYSE:FSM – Free Report) (TSE:FVI) – Analysts at Scotiabank lifted their FY2025 earnings per share estimates...
Capital One Financial Predicts CRC FY2025 Earnings
California Resources Co. (NYSE:CRC – Free Report) – Stock analysts at Capital One Financial raised their FY2025 earnings estimates for...
Zacks Research Forecasts Higher Earnings for Alliant Energy
Alliant Energy Co. (NASDAQ:LNT – Free Report) – Equities research analysts at Zacks Research lifted their Q2 2026 earnings estimates...
What is Scotiabank’s Estimate for Newmont FY2026 Earnings?
Newmont Co. (NYSE:NEM – Free Report) – Equities researchers at Scotiabank issued their FY2026 earnings per share estimates for Newmont...